Cytrx Corp (NASDAQ:CYTR)
CAPS Rating:
A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.
RSS Headlines
Fool UK
Recs
upward bias